MucormyDB Frequently Asked Questions
MucormyDB is a resource that provides a wide range of information about mucormycosis. This website has integrated genomes and proteomics data for a variety of mucormycosis-causing species. Genomics, Diagnosis, Immunotherapy, and Drug Design are some of the sub-modules that represent individual information.
There is currently no resource for studying mucormycosis. We've evaluated and aggregated genomes, proteomics, and structural data, as well as therapeutically suitable candidate, in this website. It's the first of its kind, and it's essential since it covers the entire Mucormycosis landscape.
This comprehensive resource is accessible for free to aid Mucormycosis research. To do in-house study, all vetted and annotated genomic data can be downloaded. Our website provides public access to it.
https://webs.iiitd.edu.in/raghava/mucormydb/
Mucormycosis is a devastating fungal infection that is spread by a group of moulds. The global incidence rate varies from 0.005 to 1.7 per million population due to its rarity. It has been observed that it primarily affects the immunocompromised individuals, mainly who are suffering from Diabetes, HIV/AIDS or who have had treatment with higher doses or longer courses of steroids.
Fungal species can be found in all types of environments. Fungal spores enter a person's airways when they breathe, causing severe illnesses in many parts of the body.
Skin infection develops in uncommon situations and usually affects only a skin damage. It has been found to affect the gastro-intestinal system in some uncommon circumstances. This disease do not spread from person to person.
Fungi pose little harm to healthy people, but they can cause serious infections in patients with diabetes, cancer, HIV/AIDS, a weakened immune system, or who have been treated with greater doses or longer courses of steroids.
Mucormycosis has recently been diagnosed in a large number of persons with COVID-19. It's unclear whether this is because of COVID-19 or for some other reason.